Discover five global dividend stocks that offer stable income, resilient cash flows, and long-term diversification beyond Singapore’s market. The post 5 Global Dividend Stocks to Add Stability to Your ...

Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.

Here are 10 of the most-clicked news stories about orthopedic surgeons and orthopedic practices published by Becker’s this year: 10. Nantucket (Mass.) Cottage Hospital added four orthopedic physicians ...

The U.S. president of Johnson & Johnson’s orthopedics business is leaving as the company works to spin out the segment. Leslie Storms shared details of her departure in a LinkedIn post last week.

JNJ and PFE battle patent cliffs and policy headwinds, but rising estimates and stronger 2025 momentum push JNJ ahead in this ...

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Stocks to Buy for the Long Term. On December 5, Guggenheim boosted ...

During its most recent quarterly earnings, Johnson & Johnson announced plans to separate its Orthopedics business to enhance strategic and operational focus. The transaction would establish a ...

Adolescent idiopathic scoliosis is the most prevalent spinal deformity in children, with an incidence reported between 0.47% ...

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business. The health care giant said Tuesday that it will separate its orthopedics business into ...

Johnson & Johnson JNJ faces several challenges, like potential losses from expiring drug patents, ongoing legal battles ...